BioAdvance News

Optofluidics announces Hexpoint, a new particle analysis system for early stage formulation

By WebmasterJanuary 6, 2017November 1st, 2024No Comments

Optofluidics announces Hexpoint, a new particle analysis system for early stage formulation

Previous PostRelmada Announces FDA Acceptance of IND and Authorization to Commence Phase 2a Clinical Trial for d-Methadone
Next PostH&T Presspart and Cohero Health Launch First Market-Ready, Fully-Connected Metered Dose Inhaler to Optimize care of Asthma and COPD